DNB Fund - Biotechnology A (ACC) EUR

WKN A40FC7 | ISIN LU2814038266 |  Fonds
Factsheet

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 LU0195948822 Franklin Biotechnology Discovery Fund - I (acc) USD +19,11 % +24,01 % 0,71
2 LU0976566496 Franklin Biotechnology Discovery Fund - W (acc) USD +19,02 % +24,03 % 0,71
3 LU0109394709 Franklin Biotechnology Discovery Fund - A (acc) USD +18,10 % +24,01 % 0,67
4 LU2208649280 UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse QL-acc, USD +16,51 % +22,42 % 0,64
5 LU0400035332 UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse Q-acc, USD +16,28 % +22,43 % 0,63
75 LU2814038266 DNB Fund - Biotechnology A (ACC) EUR -0,16 % +24,30 % -0,09
83 LU1725387622 Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 EUR - Accumulating -10,00 % +14,24 % -0,85
84 LU0415392678 Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating -10,12 % +14,23 % -0,86
85 LU0415392249 Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating -10,74 % +14,23 % -0,90
86 LU0415392835 Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating -11,12 % +14,55 % -0,91
87 LU0415392595 Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating -11,74 % +14,55 % -0,95